Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.75282981 |
2 | regulation of guanylate cyclase activity (GO:0031282) | 7.97297314 |
3 | NADH metabolic process (GO:0006734) | 7.13273959 |
4 | regulation of bile acid biosynthetic process (GO:0070857) | 7.00545444 |
5 | epoxygenase P450 pathway (GO:0019373) | 6.82474482 |
6 | intestinal absorption (GO:0050892) | 6.71210958 |
7 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.63153589 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.46087053 |
9 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.38590512 |
10 | modulation by symbiont of host defense response (GO:0052031) | 6.34967099 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.34967099 |
12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.34967099 |
13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.34967099 |
14 | modulation by symbiont of host immune response (GO:0052553) | 6.34967099 |
15 | positive regulation by symbiont of host defense response (GO:0052509) | 6.34967099 |
16 | fructose metabolic process (GO:0006000) | 5.73972406 |
17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.64260787 |
18 | * lipoprotein transport (GO:0042953) | 5.49823499 |
19 | neutrophil activation involved in immune response (GO:0002283) | 5.47180448 |
20 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.42363265 |
21 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.42363265 |
22 | endocrine process (GO:0050886) | 5.42363265 |
23 | hormone catabolic process (GO:0042447) | 5.34488932 |
24 | regulation of cellular extravasation (GO:0002691) | 5.27554861 |
25 | virion attachment to host cell (GO:0019062) | 5.14317315 |
26 | adhesion of symbiont to host cell (GO:0044650) | 5.14317315 |
27 | immunoglobulin mediated immune response (GO:0016064) | 5.07329004 |
28 | macrophage activation involved in immune response (GO:0002281) | 5.02224444 |
29 | vitamin A metabolic process (GO:0006776) | 5.00146428 |
30 | cellular glucuronidation (GO:0052695) | 4.99078567 |
31 | regulation of triglyceride catabolic process (GO:0010896) | 4.95858681 |
32 | glucuronate metabolic process (GO:0019585) | 4.92959850 |
33 | uronic acid metabolic process (GO:0006063) | 4.92959850 |
34 | drug metabolic process (GO:0017144) | 4.90635816 |
35 | positive regulation of interferon-alpha production (GO:0032727) | 4.87872619 |
36 | regulation of systemic arterial blood pressure (GO:0003073) | 4.87449386 |
37 | regulation of cGMP biosynthetic process (GO:0030826) | 4.83299389 |
38 | bile acid and bile salt transport (GO:0015721) | 4.82017181 |
39 | urea cycle (GO:0000050) | 4.74166762 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62684818 |
41 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.61887916 |
42 | digestion (GO:0007586) | 4.59507016 |
43 | regulation of interferon-alpha production (GO:0032647) | 4.59120436 |
44 | response to peptidoglycan (GO:0032494) | 4.54199599 |
45 | peptide hormone processing (GO:0016486) | 4.52080381 |
46 | urea metabolic process (GO:0019627) | 4.51291818 |
47 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.49368707 |
48 | diacylglycerol metabolic process (GO:0046339) | 4.49138893 |
49 | antibacterial humoral response (GO:0019731) | 4.39473775 |
50 | adhesion of symbiont to host (GO:0044406) | 4.35666768 |
51 | glycolipid catabolic process (GO:0019377) | 4.32847832 |
52 | flavonoid metabolic process (GO:0009812) | 4.28346189 |
53 | glycosphingolipid catabolic process (GO:0046479) | 4.28193821 |
54 | antimicrobial humoral response (GO:0019730) | 4.24895444 |
55 | nitrogen cycle metabolic process (GO:0071941) | 4.17319833 |
56 | plasma lipoprotein particle assembly (GO:0034377) | 4.17254238 |
57 | regulation of vitamin metabolic process (GO:0030656) | 4.15591483 |
58 | renal system process involved in regulation of blood volume (GO:0001977) | 4.13457839 |
59 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.11789727 |
60 | response to host immune response (GO:0052572) | 4.09776145 |
61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.09776145 |
62 | microglial cell activation (GO:0001774) | 4.07708364 |
63 | peptide catabolic process (GO:0043171) | 4.06115992 |
64 | regulation of cGMP metabolic process (GO:0030823) | 4.02400373 |
65 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.99540265 |
66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98832991 |
67 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.95321864 |
68 | drinking behavior (GO:0042756) | 3.95047565 |
69 | fat-soluble vitamin metabolic process (GO:0006775) | 3.91327788 |
70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.88544792 |
71 | positive regulation of pseudopodium assembly (GO:0031274) | 3.88128620 |
72 | alkaloid metabolic process (GO:0009820) | 3.86506402 |
73 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.83815969 |
74 | B cell mediated immunity (GO:0019724) | 3.81524033 |
75 | protein-lipid complex assembly (GO:0065005) | 3.80495635 |
76 | neutrophil activation (GO:0042119) | 3.78970366 |
77 | cellular response to nitric oxide (GO:0071732) | 3.78594416 |
78 | natural killer cell mediated immunity (GO:0002228) | 3.77262971 |
79 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.77262971 |
80 | granulocyte activation (GO:0036230) | 3.76216421 |
81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73589335 |
82 | myeloid cell activation involved in immune response (GO:0002275) | 3.71583176 |
83 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.68867569 |
84 | drug catabolic process (GO:0042737) | 3.68590907 |
85 | response to host (GO:0075136) | 3.67098813 |
86 | response to host defenses (GO:0052200) | 3.67098813 |
87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.67098813 |
88 | vitamin transmembrane transport (GO:0035461) | 3.66860253 |
89 | vitamin transport (GO:0051180) | 3.64330397 |
90 | daunorubicin metabolic process (GO:0044597) | 3.61083506 |
91 | polyketide metabolic process (GO:0030638) | 3.61083506 |
92 | doxorubicin metabolic process (GO:0044598) | 3.61083506 |
93 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.59921409 |
94 | homocysteine metabolic process (GO:0050667) | 3.58592770 |
95 | arginine metabolic process (GO:0006525) | 3.57528868 |
96 | macrophage activation (GO:0042116) | 3.55667759 |
97 | respiratory burst (GO:0045730) | 3.52923700 |
98 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.50234704 |
99 | midgut development (GO:0007494) | 3.49590527 |
100 | exogenous drug catabolic process (GO:0042738) | 3.48391705 |
101 | sulfate transmembrane transport (GO:1902358) | 3.48253526 |
102 | regulation of pseudopodium assembly (GO:0031272) | 3.47736767 |
103 | regulation of antigen processing and presentation (GO:0002577) | 3.47418832 |
104 | pinocytosis (GO:0006907) | 3.46402196 |
105 | phospholipid efflux (GO:0033700) | 3.45981828 |
106 | ceramide catabolic process (GO:0046514) | 3.45905635 |
107 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.45606800 |
108 | bile acid metabolic process (GO:0008206) | 3.44528971 |
109 | cGMP biosynthetic process (GO:0006182) | 3.42510669 |
110 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.42234810 |
111 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.42023503 |
112 | regulation of cholesterol homeostasis (GO:2000188) | 3.41655054 |
113 | positive regulation of interferon-beta production (GO:0032728) | 3.40334759 |
114 | B cell receptor signaling pathway (GO:0050853) | 3.37941732 |
115 | positive regulation of B cell differentiation (GO:0045579) | 3.37508525 |
116 | response to nitric oxide (GO:0071731) | 3.37415691 |
117 | vitamin biosynthetic process (GO:0009110) | 3.35566984 |
118 | glycosylceramide metabolic process (GO:0006677) | 3.35102788 |
119 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31760656 |
120 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31760656 |
121 | response to muramyl dipeptide (GO:0032495) | 3.30406528 |
122 | cellular response to reactive nitrogen species (GO:1902170) | 3.30124799 |
123 | digestive system process (GO:0022600) | 3.29732884 |
124 | regulation of cholesterol esterification (GO:0010872) | 3.29480570 |
125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.28977796 |
126 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.28977796 |
127 | sphingolipid catabolic process (GO:0030149) | 3.24468675 |
128 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.24007461 |
129 | T-helper 1 type immune response (GO:0042088) | 3.23814623 |
130 | response to type I interferon (GO:0034340) | 3.23294043 |
131 | drug transport (GO:0015893) | 3.22863107 |
132 | type I interferon signaling pathway (GO:0060337) | 3.22459840 |
133 | cellular response to type I interferon (GO:0071357) | 3.22459840 |
134 | citrulline biosynthetic process (GO:0019240) | 3.21438296 |
135 | positive regulation of cGMP metabolic process (GO:0030825) | 3.21289519 |
136 | sphingomyelin metabolic process (GO:0006684) | 3.20855327 |
137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18043146 |
138 | positive regulation of lipid catabolic process (GO:0050996) | 3.17479119 |
139 | cobalamin metabolic process (GO:0009235) | 3.16975090 |
140 | regulation of protein glycosylation (GO:0060049) | 3.14137701 |
141 | glycoside metabolic process (GO:0016137) | 3.14058861 |
142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13354974 |
143 | glycerol metabolic process (GO:0006071) | 3.11867508 |
144 | membrane lipid catabolic process (GO:0046466) | 3.11191909 |
145 | transcytosis (GO:0045056) | 3.10870708 |
146 | vitamin D metabolic process (GO:0042359) | 3.10633141 |
147 | * lipoprotein metabolic process (GO:0042157) | 3.10166883 |
148 | drug transmembrane transport (GO:0006855) | 3.08685234 |
149 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.08312893 |
150 | cyclooxygenase pathway (GO:0019371) | 3.06602451 |
151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06388035 |
152 | cGMP-mediated signaling (GO:0019934) | 3.05252203 |
153 | regulation of mast cell degranulation (GO:0043304) | 3.01316187 |
154 | detection of molecule of bacterial origin (GO:0032490) | 3.01132995 |
155 | defense response to protozoan (GO:0042832) | 3.00638480 |
156 | neutrophil mediated immunity (GO:0002446) | 3.00405593 |
157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96418573 |
158 | regulation of B cell differentiation (GO:0045577) | 2.96269470 |
159 | regulation of mast cell activation (GO:0033003) | 2.92583661 |
160 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.91636477 |
161 | regulation of cholesterol storage (GO:0010885) | 2.89151640 |
162 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.88737793 |
163 | negative regulation of mast cell activation (GO:0033004) | 2.88577760 |
164 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.88331970 |
165 | leukocyte mediated cytotoxicity (GO:0001909) | 2.88243237 |
166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88161935 |
167 | positive regulation of mast cell activation (GO:0033005) | 2.87038587 |
168 | lymphocyte mediated immunity (GO:0002449) | 2.86632396 |
169 | negative regulation of interleukin-17 production (GO:0032700) | 2.85382585 |
170 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.83911604 |
171 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83753352 |
172 | positive regulation of macrophage cytokine production (GO:0060907) | 2.83735000 |
173 | response to interferon-alpha (GO:0035455) | 2.81047638 |
174 | I-kappaB phosphorylation (GO:0007252) | 2.80254287 |
175 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.79629039 |
176 | negative regulation of phagocytosis (GO:0050765) | 2.79618922 |
177 | germinal center formation (GO:0002467) | 2.79518191 |
178 | myeloid leukocyte activation (GO:0002274) | 2.74492305 |
179 | lymphocyte chemotaxis (GO:0048247) | 2.72036704 |
180 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68851547 |
181 | negative regulation of cell killing (GO:0031342) | 2.68851547 |
182 | regulation of activation of Janus kinase activity (GO:0010533) | 2.68392165 |
183 | positive regulation of defense response to virus by host (GO:0002230) | 2.67860698 |
184 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65215007 |
185 | regulation of mononuclear cell migration (GO:0071675) | 2.64478512 |
186 | regulation of interferon-beta production (GO:0032648) | 2.64014277 |
187 | phagocytosis, engulfment (GO:0006911) | 2.61505542 |
188 | negative regulation of interleukin-12 production (GO:0032695) | 2.60888239 |
189 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.60175764 |
190 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.59952680 |
191 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.59590609 |
192 | interferon-gamma production (GO:0032609) | 2.59458122 |
193 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59296752 |
194 | negative regulation of bone resorption (GO:0045779) | 2.59065503 |
195 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58378188 |
196 | negative regulation of interleukin-6 production (GO:0032715) | 2.58287899 |
197 | response to protozoan (GO:0001562) | 2.57800387 |
198 | reactive oxygen species biosynthetic process (GO:1903409) | 2.56263922 |
199 | angiotensin maturation (GO:0002003) | 11.3168684 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.48328938 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32308848 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.88106291 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.14661585 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.97867265 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73585720 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42750864 |
8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.35920766 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.26577232 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13838349 |
11 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.07187920 |
12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.06861563 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.98089527 |
14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76472206 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.73589563 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70826461 |
17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.59365416 |
18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.56464417 |
19 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.55227774 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47307242 |
21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.46673119 |
22 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.37754911 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36411845 |
24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.34003025 |
25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31209826 |
26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30286199 |
27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27355064 |
28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24407821 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22800479 |
30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.22500807 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16706230 |
32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.06133325 |
33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.01923687 |
34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97959916 |
35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96777116 |
36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93678754 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88667280 |
38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87935377 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87372108 |
40 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.86993402 |
41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79024742 |
42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72423527 |
43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72190327 |
44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71016283 |
45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70538642 |
46 | MYB_26560356_Chip-Seq_TH2_Human | 1.69946070 |
47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.68631508 |
48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.65948616 |
49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.63985148 |
50 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.63838418 |
51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60418844 |
52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60280377 |
53 | MYB_26560356_Chip-Seq_TH1_Human | 1.58623818 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57355466 |
55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55322963 |
56 | MAF_26560356_Chip-Seq_TH1_Human | 1.55040795 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53819827 |
58 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53710113 |
59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.51443841 |
60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49592197 |
61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46745045 |
62 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45633554 |
63 | MYC_22102868_ChIP-Seq_BL_Human | 1.45242393 |
64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44980012 |
65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38755977 |
66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37205285 |
67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36890339 |
68 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.35263813 |
69 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.34003134 |
70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33697884 |
71 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33517027 |
72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31390558 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30447969 |
74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30318800 |
75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28528450 |
76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28527663 |
77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27871945 |
78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26891476 |
79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.26594451 |
80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25716022 |
81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25451831 |
82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25327911 |
83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24333865 |
84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23936323 |
85 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.23804699 |
86 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.23804699 |
87 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.23804699 |
88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23791975 |
89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22908541 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20822695 |
91 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20747687 |
92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20150942 |
93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19006578 |
94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17135311 |
95 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16901794 |
96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16130016 |
97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15144000 |
98 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.11270237 |
99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11071903 |
100 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10255346 |
101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09067370 |
102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09004646 |
103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08762326 |
104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08523090 |
105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.08089065 |
106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07488770 |
107 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06793205 |
108 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06579956 |
109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06240214 |
110 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06025402 |
111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05793616 |
112 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04033107 |
113 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03754460 |
114 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03268024 |
115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02957109 |
116 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02823401 |
117 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02181160 |
118 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02159474 |
119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01587602 |
120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01018558 |
121 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00041067 |
122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99733399 |
123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99617668 |
124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99492080 |
125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99346371 |
126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97910190 |
127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96468852 |
128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96232912 |
129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95862163 |
130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95765510 |
131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94140144 |
132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90778084 |
133 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90635026 |
134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90396838 |
135 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88959032 |
136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88681254 |
137 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88604882 |
138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88235005 |
139 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87552949 |
140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86242422 |
141 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85991788 |
142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84643516 |
143 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84144489 |
144 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83924147 |
145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83413367 |
146 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82491802 |
147 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82165857 |
148 | MAF_26560356_Chip-Seq_TH2_Human | 0.81977963 |
149 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81843486 |
150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81515620 |
151 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.81347039 |
152 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80790539 |
153 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80651078 |
154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80384211 |
155 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80181107 |
156 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80094447 |
157 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79893914 |
158 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78846435 |
159 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78414804 |
160 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.78196957 |
161 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77988181 |
162 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77898286 |
163 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76428855 |
164 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.75950319 |
165 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75666187 |
166 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.75152344 |
167 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74071188 |
168 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.73512077 |
169 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72999310 |
170 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72960234 |
171 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72311011 |
172 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71449372 |
173 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69416089 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 9.26860339 |
2 | MP0001666_abnormal_nutrient_absorption | 4.91571112 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.88196376 |
4 | MP0001835_abnormal_antigen_presentation | 4.56050250 |
5 | MP0004147_increased_porphyrin_level | 3.85220846 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.85141712 |
7 | MP0004019_abnormal_vitamin_homeostasis | 3.77592477 |
8 | MP0005365_abnormal_bile_salt | 3.75875307 |
9 | MP0009379_abnormal_foot_pigmentation | 3.52697272 |
10 | MP0005058_abnormal_lysosome_morphology | 3.50450736 |
11 | MP0003436_decreased_susceptibility_to | 3.36762095 |
12 | MP0006082_CNS_inflammation | 3.20423674 |
13 | MP0003172_abnormal_lysosome_physiology | 2.91656557 |
14 | MP0001790_abnormal_immune_system | 2.80278132 |
15 | MP0005387_immune_system_phenotype | 2.80278132 |
16 | MP0002419_abnormal_innate_immunity | 2.77783573 |
17 | MP0005000_abnormal_immune_tolerance | 2.77000420 |
18 | MP0009785_altered_susceptibility_to | 2.67603331 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.67303159 |
20 | MP0001800_abnormal_humoral_immune | 2.66101866 |
21 | MP0000569_abnormal_digit_pigmentation | 2.60743265 |
22 | MP0002452_abnormal_antigen_presenting | 2.57384627 |
23 | MP0000685_abnormal_immune_system | 2.56941906 |
24 | MP0002254_reproductive_system_inflammat | 2.56870023 |
25 | MP0010234_abnormal_vibrissa_follicle | 2.52725769 |
26 | MP0005025_abnormal_response_to | 2.51040250 |
27 | MP0003183_abnormal_peptide_metabolism | 2.45769878 |
28 | MP0003303_peritoneal_inflammation | 2.43453519 |
29 | MP0005671_abnormal_response_to | 2.37147404 |
30 | MP0002723_abnormal_immune_serum | 2.32712615 |
31 | MP0003191_abnormal_cellular_cholesterol | 2.27466662 |
32 | MP0001819_abnormal_immune_cell | 2.11427718 |
33 | MP0002420_abnormal_adaptive_immunity | 2.10287861 |
34 | MP0009840_abnormal_foam_cell | 2.07429113 |
35 | MP0001664_abnormal_digestion | 2.06776939 |
36 | MP0003866_abnormal_defecation | 1.99359417 |
37 | MP0005409_darkened_coat_color | 1.99329097 |
38 | MP0005464_abnormal_platelet_physiology | 1.87099941 |
39 | MP0005332_abnormal_amino_acid | 1.83589947 |
40 | MP0009643_abnormal_urine_homeostasis | 1.80308202 |
41 | MP0002405_respiratory_system_inflammati | 1.79143671 |
42 | MP0003868_abnormal_feces_composition | 1.75636050 |
43 | MP0005310_abnormal_salivary_gland | 1.74485868 |
44 | MP0001853_heart_inflammation | 1.72140957 |
45 | * MP0010329_abnormal_lipoprotein_level | 1.68973283 |
46 | MP0005257_abnormal_intraocular_pressure | 1.68290433 |
47 | MP0004510_myositis | 1.67955461 |
48 | MP0001845_abnormal_inflammatory_respons | 1.67266712 |
49 | MP0003806_abnormal_nucleotide_metabolis | 1.66698272 |
50 | MP0003252_abnormal_bile_duct | 1.66324320 |
51 | MP0001533_abnormal_skeleton_physiology | 1.66314821 |
52 | MP0003724_increased_susceptibility_to | 1.64230232 |
53 | MP0000716_abnormal_immune_system | 1.63861971 |
54 | MP0003300_gastrointestinal_ulcer | 1.61344475 |
55 | MP0000538_abnormal_urinary_bladder | 1.59700032 |
56 | MP0004947_skin_inflammation | 1.58784141 |
57 | MP0000689_abnormal_spleen_morphology | 1.56151251 |
58 | MP0002166_altered_tumor_susceptibility | 1.55530141 |
59 | MP0002398_abnormal_bone_marrow | 1.55379411 |
60 | MP0008469_abnormal_protein_level | 1.54548399 |
61 | MP0001764_abnormal_homeostasis | 1.52296971 |
62 | MP0002396_abnormal_hematopoietic_system | 1.48127770 |
63 | MP0002277_abnormal_respiratory_mucosa | 1.46965181 |
64 | MP0003448_altered_tumor_morphology | 1.46774856 |
65 | MP0000477_abnormal_intestine_morphology | 1.45657683 |
66 | MP0010155_abnormal_intestine_physiology | 1.42777120 |
67 | MP0001765_abnormal_ion_homeostasis | 1.40322683 |
68 | MP0000343_altered_response_to | 1.39670881 |
69 | MP0003718_maternal_effect | 1.39577879 |
70 | MP0002429_abnormal_blood_cell | 1.37157632 |
71 | MP0003011_delayed_dark_adaptation | 1.36453920 |
72 | MP0009764_decreased_sensitivity_to | 1.36025424 |
73 | MP0005636_abnormal_mineral_homeostasis | 1.34773140 |
74 | MP0002722_abnormal_immune_system | 1.34395984 |
75 | MP0000604_amyloidosis | 1.31252215 |
76 | MP0010307_abnormal_tumor_latency | 1.29190749 |
77 | MP0005670_abnormal_white_adipose | 1.28426160 |
78 | MP0000678_abnormal_parathyroid_gland | 1.27827177 |
79 | MP0002006_tumorigenesis | 1.23990214 |
80 | MP0001188_hyperpigmentation | 1.22964535 |
81 | MP0003690_abnormal_glial_cell | 1.22830791 |
82 | MP0005174_abnormal_tail_pigmentation | 1.20178025 |
83 | MP0003075_altered_response_to | 1.19342190 |
84 | MP0002998_abnormal_bone_remodeling | 1.17658171 |
85 | MP0004858_abnormal_nervous_system | 1.17027772 |
86 | MP0003879_abnormal_hair_cell | 1.16924586 |
87 | MP0001501_abnormal_sleep_pattern | 1.16117689 |
88 | MP0001663_abnormal_digestive_system | 1.15953479 |
89 | MP0000858_altered_metastatic_potential | 1.15864660 |
90 | MP0002876_abnormal_thyroid_physiology | 1.13424269 |
91 | MP0002822_catalepsy | 1.12007031 |
92 | * MP0002118_abnormal_lipid_homeostasis | 1.10644723 |
93 | MP0009278_abnormal_bone_marrow | 1.08392401 |
94 | MP0005448_abnormal_energy_balance | 1.08307895 |
95 | MP0003705_abnormal_hypodermis_morpholog | 1.04335148 |
96 | MP0001545_abnormal_hematopoietic_system | 1.03798912 |
97 | MP0005397_hematopoietic_system_phenotyp | 1.03798912 |
98 | MP0000462_abnormal_digestive_system | 1.03219684 |
99 | MP0004270_analgesia | 1.02218345 |
100 | MP0009333_abnormal_splenocyte_physiolog | 1.00664131 |
101 | MP0005535_abnormal_body_temperature | 0.98840338 |
102 | MP0004264_abnormal_extraembryonic_tissu | 0.98239900 |
103 | MP0005075_abnormal_melanosome_morpholog | 0.97299004 |
104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97200799 |
105 | MP0009763_increased_sensitivity_to | 0.95908749 |
106 | MP0005381_digestive/alimentary_phenotyp | 0.95770028 |
107 | MP0003566_abnormal_cell_adhesion | 0.95046935 |
108 | MP0000609_abnormal_liver_physiology | 0.91854834 |
109 | MP0000465_gastrointestinal_hemorrhage | 0.91818704 |
110 | MP0005076_abnormal_cell_differentiation | 0.89324022 |
111 | MP0004043_abnormal_pH_regulation | 0.88428030 |
112 | MP0010352_gastrointestinal_tract_polyps | 0.87726245 |
113 | MP0005166_decreased_susceptibility_to | 0.87663999 |
114 | MP0002138_abnormal_hepatobiliary_system | 0.87595887 |
115 | MP0002971_abnormal_brown_adipose | 0.87300305 |
116 | MP0003828_pulmonary_edema | 0.86963263 |
117 | MP0001873_stomach_inflammation | 0.86570954 |
118 | MP0004782_abnormal_surfactant_physiolog | 0.86335790 |
119 | MP0000490_abnormal_crypts_of | 0.86107693 |
120 | MP0002933_joint_inflammation | 0.85704155 |
121 | MP0005451_abnormal_body_composition | 0.85696841 |
122 | MP0005390_skeleton_phenotype | 0.84712517 |
123 | MP0000371_diluted_coat_color | 0.83751261 |
124 | MP0000015_abnormal_ear_pigmentation | 0.81089186 |
125 | MP0000230_abnormal_systemic_arterial | 0.79675450 |
126 | MP0001756_abnormal_urination | 0.79391460 |
127 | MP0008004_abnormal_stomach_pH | 0.79074825 |
128 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78410887 |
129 | MP0002332_abnormal_exercise_endurance | 0.76565355 |
130 | MP0005164_abnormal_response_to | 0.75935077 |
131 | MP0002796_impaired_skin_barrier | 0.74194923 |
132 | MP0002098_abnormal_vibrissa_morphology | 0.72798317 |
133 | MP0003186_abnormal_redox_activity | 0.72531960 |
134 | MP0004808_abnormal_hematopoietic_stem | 0.71846808 |
135 | MP0005319_abnormal_enzyme/_coenzyme | 0.70948030 |
136 | MP0003656_abnormal_erythrocyte_physiolo | 0.70430738 |
137 | MP0003795_abnormal_bone_structure | 0.70285157 |
138 | MP0000703_abnormal_thymus_morphology | 0.70200030 |
139 | MP0001851_eye_inflammation | 0.69355866 |
140 | MP0000013_abnormal_adipose_tissue | 0.69267327 |
141 | MP0005023_abnormal_wound_healing | 0.68675325 |
142 | MP0005167_abnormal_blood-brain_barrier | 0.68546804 |
143 | MP0002136_abnormal_kidney_physiology | 0.68255077 |
144 | MP0003763_abnormal_thymus_physiology | 0.67800708 |
145 | * MP0009642_abnormal_blood_homeostasis | 0.67764932 |
146 | MP0000537_abnormal_urethra_morphology | 0.67259053 |
147 | * MP0000249_abnormal_blood_vessel | 0.66629590 |
148 | MP0000598_abnormal_liver_morphology | 0.66132378 |
149 | MP0001485_abnormal_pinna_reflex | 0.65870982 |
150 | MP0009115_abnormal_fat_cell | 0.64355530 |
151 | MP0008872_abnormal_physiological_respon | 0.63291230 |
152 | MP0008057_abnormal_DNA_replication | 0.61548276 |
153 | MP0004883_abnormal_blood_vessel | 0.61479531 |
154 | MP0001243_abnormal_dermal_layer | 0.59160099 |
155 | MP0005501_abnormal_skin_physiology | 0.56780255 |
156 | MP0005334_abnormal_fat_pad | 0.55158009 |
157 | MP0005666_abnormal_adipose_tissue | 0.53829567 |
158 | MP0006138_congestive_heart_failure | 0.51960550 |
159 | MP0002896_abnormal_bone_mineralization | 0.50948469 |
160 | MP0005165_increased_susceptibility_to | 0.50718334 |
161 | MP0008260_abnormal_autophagy | 0.49388407 |
162 | MP0003953_abnormal_hormone_level | 0.49312625 |
163 | MP0002078_abnormal_glucose_homeostasis | 0.48746875 |
164 | MP0001881_abnormal_mammary_gland | 0.48208127 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Malnutrition (HP:0004395) | 7.29632321 |
2 | Hydroxyprolinuria (HP:0003080) | 7.13388429 |
3 | Abnormality of proline metabolism (HP:0010907) | 7.13388429 |
4 | Recurrent abscess formation (HP:0002722) | 6.12982416 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.07445512 |
6 | Recurrent bacterial skin infections (HP:0005406) | 5.57694852 |
7 | Chronic diarrhea (HP:0002028) | 5.47858418 |
8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.36144355 |
9 | Eczematoid dermatitis (HP:0000976) | 5.08459325 |
10 | Acanthocytosis (HP:0001927) | 5.03168962 |
11 | Abnormality of vitamin B metabolism (HP:0004340) | 5.00649896 |
12 | Ileus (HP:0002595) | 4.89478694 |
13 | Fat malabsorption (HP:0002630) | 4.88091219 |
14 | Vacuolated lymphocytes (HP:0001922) | 4.78608138 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.67425449 |
16 | Systemic lupus erythematosus (HP:0002725) | 4.64296227 |
17 | Widely patent fontanelles and sutures (HP:0004492) | 4.57384329 |
18 | Confusion (HP:0001289) | 4.47689511 |
19 | Increased cerebral lipofuscin (HP:0011813) | 4.33048274 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 4.11645699 |
21 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.11645699 |
22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.11645699 |
23 | Abnormality of macrophages (HP:0004311) | 4.02347348 |
24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01437581 |
25 | Pigmentary retinal degeneration (HP:0001146) | 4.01417824 |
26 | Nausea (HP:0002018) | 3.99945093 |
27 | Abnormality of vitamin metabolism (HP:0100508) | 3.96984955 |
28 | Myositis (HP:0100614) | 3.92264329 |
29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.84901812 |
30 | Autoimmune thrombocytopenia (HP:0001973) | 3.80116218 |
31 | Hyperglycinuria (HP:0003108) | 3.78530682 |
32 | Glycosuria (HP:0003076) | 3.76705624 |
33 | Abnormality of urine glucose concentration (HP:0011016) | 3.76705624 |
34 | Gingivitis (HP:0000230) | 3.69851463 |
35 | Orchitis (HP:0100796) | 3.68694908 |
36 | Thin bony cortex (HP:0002753) | 3.66744691 |
37 | Recurrent skin infections (HP:0001581) | 3.59986086 |
38 | Proximal tubulopathy (HP:0000114) | 3.56369654 |
39 | Dysostosis multiplex (HP:0000943) | 3.56036337 |
40 | Wide cranial sutures (HP:0010537) | 3.39912669 |
41 | Hyperactive renin-angiotensin system (HP:0000841) | 3.36775537 |
42 | Decreased circulating renin level (HP:0003351) | 3.35328526 |
43 | Recurrent fungal infections (HP:0002841) | 3.33224116 |
44 | Axonal loss (HP:0003447) | 3.29028021 |
45 | Nephrolithiasis (HP:0000787) | 3.28581958 |
46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.22818065 |
47 | Abnormality of glycine metabolism (HP:0010895) | 3.22818065 |
48 | Upper motor neuron abnormality (HP:0002127) | 3.21291301 |
49 | Alkalosis (HP:0001948) | 3.20580336 |
50 | Mediastinal lymphadenopathy (HP:0100721) | 3.19660643 |
51 | Metabolic alkalosis (HP:0200114) | 3.19009485 |
52 | Glomerulonephritis (HP:0000099) | 3.14294440 |
53 | Recurrent viral infections (HP:0004429) | 3.14129595 |
54 | Cellulitis (HP:0100658) | 3.12357942 |
55 | Periodontitis (HP:0000704) | 3.12350596 |
56 | Congenital sensorineural hearing impairment (HP:0008527) | 3.11990222 |
57 | Disinhibition (HP:0000734) | 3.10663025 |
58 | Prostate neoplasm (HP:0100787) | 3.08503984 |
59 | Abdominal distention (HP:0003270) | 3.04812201 |
60 | Xanthomatosis (HP:0000991) | 3.04387929 |
61 | Steatorrhea (HP:0002570) | 3.03657134 |
62 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00989876 |
63 | Mucopolysacchariduria (HP:0008155) | 3.00989876 |
64 | Hyperuricemia (HP:0002149) | 2.98863406 |
65 | Increased purine levels (HP:0004368) | 2.98863406 |
66 | Myocardial infarction (HP:0001658) | 2.98806012 |
67 | Posterior subcapsular cataract (HP:0007787) | 2.96422162 |
68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.95404427 |
69 | Hypophosphatemia (HP:0002148) | 2.93143266 |
70 | Hypolipoproteinemia (HP:0010981) | 2.92789609 |
71 | Vasculitis (HP:0002633) | 2.92532626 |
72 | Optic neuritis (HP:0100653) | 2.92042087 |
73 | Retrobulbar optic neuritis (HP:0100654) | 2.92042087 |
74 | Agnosia (HP:0010524) | 2.91385272 |
75 | Megaloblastic anemia (HP:0001889) | 2.90488063 |
76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89578782 |
77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89578782 |
78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89578782 |
79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.85457448 |
80 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.84434822 |
81 | Colitis (HP:0002583) | 2.77618650 |
82 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.76680104 |
83 | Villous atrophy (HP:0011473) | 2.76680104 |
84 | Potter facies (HP:0002009) | 2.75884910 |
85 | Facial shape deformation (HP:0011334) | 2.75884910 |
86 | Hyperammonemia (HP:0001987) | 2.75002244 |
87 | Enlarged epiphyses (HP:0010580) | 2.73145324 |
88 | Abnormal urine phosphate concentration (HP:0012599) | 2.71222598 |
89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70740484 |
90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70740484 |
91 | Hyperparathyroidism (HP:0000843) | 2.70371748 |
92 | Abnormality of purine metabolism (HP:0004352) | 2.70250719 |
93 | Obstructive lung disease (HP:0006536) | 2.70159586 |
94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70159586 |
95 | Delayed epiphyseal ossification (HP:0002663) | 2.69649362 |
96 | Abnormality of renin-angiotensin system (HP:0000847) | 2.68632779 |
97 | Osteomyelitis (HP:0002754) | 2.62189750 |
98 | Basal ganglia calcification (HP:0002135) | 2.61901541 |
99 | Pustule (HP:0200039) | 2.61065152 |
100 | Meningitis (HP:0001287) | 2.53349834 |
101 | Hyperphosphaturia (HP:0003109) | 2.52720557 |
102 | Complement deficiency (HP:0004431) | 2.46908291 |
103 | Pulmonary infiltrates (HP:0002113) | 2.46900394 |
104 | Abnormality of the costochondral junction (HP:0000919) | 2.44796999 |
105 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43645951 |
106 | Inflammation of the large intestine (HP:0002037) | 2.43129031 |
107 | Loss of speech (HP:0002371) | 2.43120959 |
108 | Focal segmental glomerulosclerosis (HP:0000097) | 2.42689955 |
109 | Gingival bleeding (HP:0000225) | 2.42568341 |
110 | Abnormality of complement system (HP:0005339) | 2.41435945 |
111 | Abnormality of nucleobase metabolism (HP:0010932) | 2.41407364 |
112 | Pathologic fracture (HP:0002756) | 2.39591114 |
113 | Recurrent pneumonia (HP:0006532) | 2.37677470 |
114 | Hypotension (HP:0002615) | 2.33102040 |
115 | Agammaglobulinemia (HP:0004432) | 2.32491436 |
116 | Metabolic acidosis (HP:0001942) | 2.31418578 |
117 | Leukocytosis (HP:0001974) | 2.31377750 |
118 | Joint hemorrhage (HP:0005261) | 2.29699641 |
119 | Urticaria (HP:0001025) | 2.29569517 |
120 | Spontaneous hematomas (HP:0007420) | 2.29064708 |
121 | Cerebral palsy (HP:0100021) | 2.27254747 |
122 | Recurrent lower respiratory tract infections (HP:0002783) | 2.27022746 |
123 | Abnormality of the prostate (HP:0008775) | 2.24123005 |
124 | Premature loss of primary teeth (HP:0006323) | 2.23609643 |
125 | Hematochezia (HP:0002573) | 2.23421046 |
126 | Epidermoid cyst (HP:0200040) | 2.22941567 |
127 | Right ventricular cardiomyopathy (HP:0011663) | 2.22600593 |
128 | Poikilocytosis (HP:0004447) | 2.21606177 |
129 | Gastrointestinal inflammation (HP:0004386) | 2.21508944 |
130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21072160 |
131 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20092646 |
132 | Thick nail (HP:0001805) | 2.19544332 |
133 | Interstitial pulmonary disease (HP:0006530) | 2.18619058 |
134 | Abnormal glucose tolerance (HP:0001952) | 2.16965957 |
135 | Nasal polyposis (HP:0100582) | 2.14743592 |
136 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.14741366 |
137 | Hemorrhage of the eye (HP:0011885) | 2.14375896 |
138 | Subcapsular cataract (HP:0000523) | 2.13481385 |
139 | Amyloidosis (HP:0011034) | 2.12200334 |
140 | Cheilitis (HP:0100825) | 2.10204180 |
141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09572685 |
142 | Gout (HP:0001997) | 2.09517941 |
143 | Hepatosplenomegaly (HP:0001433) | 2.08124355 |
144 | Dicarboxylic aciduria (HP:0003215) | 2.05736857 |
145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05736857 |
146 | Arterial thrombosis (HP:0004420) | 2.05326181 |
147 | Renal tubular acidosis (HP:0001947) | 2.04265887 |
148 | Eosinophilia (HP:0001880) | 2.04023105 |
149 | Petechiae (HP:0000967) | 2.03213297 |
150 | Chest pain (HP:0100749) | 2.02487387 |
151 | Nephritis (HP:0000123) | 2.00896661 |
152 | Hyperphosphatemia (HP:0002905) | 2.00895875 |
153 | Pancreatitis (HP:0001733) | 2.00772049 |
154 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.6890204 |
155 | Abnormality of T cell physiology (HP:0011840) | 1.99947683 |
156 | Stomatitis (HP:0010280) | 1.98643188 |
157 | Protuberant abdomen (HP:0001538) | 1.97890854 |
158 | Peritonitis (HP:0002586) | 1.96484623 |
159 | Hypochromic microcytic anemia (HP:0004840) | 1.95123361 |
160 | Gastrointestinal dysmotility (HP:0002579) | 1.94893401 |
161 | Irritability (HP:0000737) | 1.94811485 |
162 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94553058 |
163 | Hemoptysis (HP:0002105) | 1.94203688 |
164 | Abnormality of the nasal mucosa (HP:0000433) | 1.92109483 |
165 | Increased IgM level (HP:0003496) | 1.91988895 |
166 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91389572 |
167 | Osteolytic defects of the hand bones (HP:0009699) | 1.91389572 |
168 | Growth hormone excess (HP:0000845) | 1.89642325 |
169 | Combined immunodeficiency (HP:0005387) | 1.88462543 |
170 | Renal tubular dysfunction (HP:0000124) | 1.87935467 |
171 | Gastrointestinal infarctions (HP:0005244) | 1.87553610 |
172 | Glomerulosclerosis (HP:0000096) | 1.86948981 |
173 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86709399 |
174 | Panhypogammaglobulinemia (HP:0003139) | 1.86689044 |
175 | Recurrent bronchitis (HP:0002837) | 1.86615610 |
176 | Bone pain (HP:0002653) | 1.86224520 |
177 | Multiple lipomas (HP:0001012) | 1.86051598 |
178 | Anorexia (HP:0002039) | 1.85548312 |
179 | Peripheral demyelination (HP:0011096) | 1.84278084 |
180 | Poor head control (HP:0002421) | 1.84259098 |
181 | Metaphyseal irregularity (HP:0003025) | 1.81469095 |
182 | Encephalitis (HP:0002383) | 1.81009139 |
183 | Hypoalbuminemia (HP:0003073) | 1.80143171 |
184 | Abnormal albumin level (HP:0012116) | 1.80143171 |
185 | Restrictive lung disease (HP:0002091) | 1.80113750 |
186 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78476409 |
187 | Dehydration (HP:0001944) | 1.77832036 |
188 | Flat acetabular roof (HP:0003180) | 1.72905554 |
189 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70645459 |
190 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70107371 |
191 | Lethargy (HP:0001254) | 1.68463909 |
192 | Symptomatic seizures (HP:0011145) | 1.68162091 |
193 | Hyperaldosteronism (HP:0000859) | 1.67532926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 4.35128516 |
2 | ERN1 | 4.02965719 |
3 | CDK12 | 3.52554438 |
4 | KIT | 3.21197602 |
5 | CSF1R | 3.05638609 |
6 | TGFBR2 | 2.99691066 |
7 | TYK2 | 2.96479788 |
8 | BLK | 2.95644578 |
9 | EPHA2 | 2.95571345 |
10 | MAP3K14 | 2.74449608 |
11 | TBK1 | 2.57887964 |
12 | MAP4K1 | 2.55860128 |
13 | RIPK4 | 2.54232191 |
14 | IRAK4 | 2.43710786 |
15 | STK39 | 2.43527141 |
16 | TAOK3 | 2.42912542 |
17 | GRK6 | 2.38898769 |
18 | IRAK3 | 2.09792538 |
19 | IKBKB | 1.92000990 |
20 | STK10 | 1.90881331 |
21 | OXSR1 | 1.88636016 |
22 | MAP3K12 | 1.87900893 |
23 | TESK2 | 1.87736011 |
24 | IKBKE | 1.81227856 |
25 | JAK3 | 1.72121903 |
26 | MET | 1.69266961 |
27 | EPHB2 | 1.67407596 |
28 | MATK | 1.65727153 |
29 | JAK1 | 1.64613678 |
30 | MAP3K2 | 1.61765731 |
31 | SYK | 1.59911349 |
32 | GRK7 | 1.58547000 |
33 | CSK | 1.56482034 |
34 | PDK2 | 1.53492297 |
35 | BTK | 1.41164743 |
36 | HCK | 1.40065745 |
37 | STK24 | 1.39030029 |
38 | GRK5 | 1.38266449 |
39 | CASK | 1.35655309 |
40 | TNIK | 1.35573522 |
41 | FGFR3 | 1.32611427 |
42 | ZAP70 | 1.31721621 |
43 | CHUK | 1.29419740 |
44 | MAP3K13 | 1.28545007 |
45 | CAMK1D | 1.28298292 |
46 | ADRBK2 | 1.25197999 |
47 | LYN | 1.24219825 |
48 | ITK | 1.21360738 |
49 | AKT3 | 1.20080176 |
50 | TEC | 1.19493429 |
51 | DDR2 | 1.18923569 |
52 | PIK3CA | 1.18803127 |
53 | MYLK | 1.13304249 |
54 | NEK9 | 1.13035010 |
55 | PIM2 | 1.11226591 |
56 | MOS | 1.10066068 |
57 | MAP2K3 | 1.08529964 |
58 | GRK1 | 1.08165648 |
59 | MAP2K2 | 1.07492633 |
60 | LCK | 1.07472315 |
61 | MAP3K1 | 1.03744855 |
62 | EPHA4 | 1.02424552 |
63 | LMTK2 | 1.00055695 |
64 | MAP3K10 | 0.96217052 |
65 | FGFR4 | 0.94711279 |
66 | MAPK7 | 0.94399665 |
67 | EPHB1 | 0.93882782 |
68 | NME2 | 0.92860186 |
69 | JAK2 | 0.92561572 |
70 | FES | 0.91530102 |
71 | PIM1 | 0.91317250 |
72 | PRPF4B | 0.90679391 |
73 | RIPK1 | 0.89912237 |
74 | TXK | 0.88792292 |
75 | CAMK1G | 0.87311651 |
76 | TESK1 | 0.86877760 |
77 | RPS6KA4 | 0.86793439 |
78 | PDPK1 | 0.85518010 |
79 | ERBB2 | 0.83030648 |
80 | STK4 | 0.80224247 |
81 | MAP3K3 | 0.78660797 |
82 | NLK | 0.78307319 |
83 | PRKCD | 0.75703975 |
84 | PAK4 | 0.74430610 |
85 | EIF2AK2 | 0.74236629 |
86 | MAP3K11 | 0.72856504 |
87 | FLT3 | 0.71360142 |
88 | HIPK2 | 0.70730029 |
89 | PRKACG | 0.68939515 |
90 | PBK | 0.68911770 |
91 | PRKAA2 | 0.66375398 |
92 | CDC42BPA | 0.64717071 |
93 | FGR | 0.64160489 |
94 | PDK1 | 0.62292175 |
95 | SIK2 | 0.61816535 |
96 | TAOK1 | 0.61195558 |
97 | EGFR | 0.60974336 |
98 | TLK1 | 0.60431750 |
99 | MAP2K6 | 0.60410524 |
100 | PRKCA | 0.59681628 |
101 | MST4 | 0.59133910 |
102 | ABL1 | 0.57994472 |
103 | TTN | 0.56863796 |
104 | SCYL2 | 0.56714673 |
105 | PRKG2 | 0.56372379 |
106 | PRKCZ | 0.56302852 |
107 | CDK6 | 0.55414278 |
108 | MARK3 | 0.55406962 |
109 | CAMK4 | 0.54779497 |
110 | IRAK1 | 0.53814608 |
111 | CDK19 | 0.53148228 |
112 | FER | 0.52724478 |
113 | DYRK1B | 0.51310070 |
114 | IGF1R | 0.49489069 |
115 | PTK6 | 0.47699655 |
116 | TRPM7 | 0.44932662 |
117 | SRC | 0.44853483 |
118 | PIK3CG | 0.44138080 |
119 | MAPKAPK2 | 0.43956052 |
120 | PTK2 | 0.43408832 |
121 | MAPK12 | 0.42827104 |
122 | CLK1 | 0.42591331 |
123 | CAMK2D | 0.42072696 |
124 | LRRK2 | 0.41439746 |
125 | DAPK2 | 0.40081481 |
126 | MAPK11 | 0.39768807 |
127 | PRKCQ | 0.38285587 |
128 | EPHA3 | 0.38200576 |
129 | TRIB3 | 0.37303129 |
130 | RET | 0.35874096 |
131 | KSR2 | 0.34944353 |
132 | CAMKK2 | 0.34435089 |
133 | YES1 | 0.34179041 |
134 | BMPR2 | 0.33317884 |
135 | PDGFRA | 0.31445126 |
136 | BMX | 0.29383458 |
137 | CDK4 | 0.28842498 |
138 | WNK1 | 0.28194158 |
139 | MELK | 0.28179768 |
140 | KDR | 0.28130475 |
141 | CAMK2G | 0.27890925 |
142 | FYN | 0.27671541 |
143 | PRKCH | 0.26974213 |
144 | PRKCI | 0.26845031 |
145 | TTK | 0.26542459 |
146 | NEK6 | 0.25040927 |
147 | MAP3K8 | 0.24724348 |
148 | INSR | 0.24315043 |
149 | ABL2 | 0.24255847 |
150 | CAMK2B | 0.22170461 |
151 | ACVR1B | 0.20242697 |
152 | MAPK4 | 0.18185718 |
153 | BRD4 | 0.17335155 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.14748516 |
2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.74091245 |
3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.45261565 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.57560954 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.13173840 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92445793 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.74628777 |
8 | Lysosome_Homo sapiens_hsa04142 | 2.73947543 |
9 | Mineral absorption_Homo sapiens_hsa04978 | 2.60171255 |
10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.58326459 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.57314494 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39137102 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31399722 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.30632089 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25355421 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21530433 |
17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15284022 |
18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.13266350 |
19 | Tuberculosis_Homo sapiens_hsa05152 | 2.05690072 |
20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.05181866 |
21 | Pertussis_Homo sapiens_hsa05133 | 2.01109066 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00524258 |
23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.95724988 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94996099 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.94340121 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.91197364 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90576344 |
28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.88545059 |
29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80650317 |
30 | Measles_Homo sapiens_hsa05162 | 1.79881891 |
31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.76161510 |
32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69441249 |
33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68090945 |
34 | Malaria_Homo sapiens_hsa05144 | 1.65710102 |
35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64565025 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.63255559 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62985788 |
38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61410078 |
39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.58598118 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.57726967 |
41 | Allograft rejection_Homo sapiens_hsa05330 | 1.57561137 |
42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56237051 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53372250 |
44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53139534 |
45 | Phagosome_Homo sapiens_hsa04145 | 1.52508581 |
46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44891380 |
47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44471264 |
48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42373974 |
49 | Apoptosis_Homo sapiens_hsa04210 | 1.40751049 |
50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39119839 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39020999 |
52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35626418 |
53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31789493 |
54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31364185 |
55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26651238 |
56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26014980 |
57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22070765 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.19690841 |
59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19529276 |
60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16641508 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16393560 |
62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13791102 |
63 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11422916 |
64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10868366 |
65 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.10628563 |
66 | Salmonella infection_Homo sapiens_hsa05132 | 1.10520500 |
67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10105858 |
68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08548480 |
69 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03838792 |
70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00795361 |
71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98659841 |
72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96777729 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.96297371 |
74 | Shigellosis_Homo sapiens_hsa05131 | 0.95133109 |
75 | Hepatitis B_Homo sapiens_hsa05161 | 0.93966991 |
76 | Asthma_Homo sapiens_hsa05310 | 0.92025749 |
77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91368869 |
78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89018975 |
79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86391600 |
80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83679694 |
81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76134779 |
82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75058686 |
83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74624617 |
84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73821614 |
85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73809378 |
86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72109205 |
87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71619555 |
88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71508628 |
89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65638022 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61901168 |
91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61401781 |
92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60996549 |
93 | ABC transporters_Homo sapiens_hsa02010 | 0.60539800 |
94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59672476 |
95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58153187 |
96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57317356 |
97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54096828 |
98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53411727 |
99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53187335 |
100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52499145 |
101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50803888 |
102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49634852 |
103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49573654 |
104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48886432 |
105 | Platelet activation_Homo sapiens_hsa04611 | 0.48465287 |
106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47893388 |
107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47780302 |
108 | Peroxisome_Homo sapiens_hsa04146 | 0.46972666 |
109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43215271 |
110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43204075 |
111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42873948 |
112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41939696 |
113 | Amoebiasis_Homo sapiens_hsa05146 | 0.41227042 |
114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41117413 |
115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40386209 |
116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39492415 |
117 | Prion diseases_Homo sapiens_hsa05020 | 0.38368530 |
118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36971259 |
119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36698117 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35314741 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35085434 |
122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34503850 |
123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33838151 |
124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33773122 |
125 | Renin secretion_Homo sapiens_hsa04924 | 0.32838806 |
126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32829663 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.31646826 |
128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30601778 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.29877524 |
130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29116482 |
131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28801723 |
132 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28612893 |
133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28312949 |
134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28154856 |
135 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27863276 |
136 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27581604 |
137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24949620 |
138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.24461971 |
139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23215134 |
140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23175599 |
141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22844375 |
142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22828636 |
143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21933374 |
144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.18969535 |
145 | Carbon metabolism_Homo sapiens_hsa01200 | 0.16749796 |
146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10672608 |
147 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08251081 |
148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08134569 |
149 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.05986054 |
150 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.05835986 |
151 | Insulin secretion_Homo sapiens_hsa04911 | 0.04666907 |
152 | Tight junction_Homo sapiens_hsa04530 | 0.04369319 |
153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.01443925 |
154 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.01364918 |
155 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0246114 |
156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0236147 |
157 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0012901 |